Qube Research & Technologies Ltd - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 94 filers reported holding ZIOPHARM ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.0%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q3 2023$233
-99.3%
1,766
-96.7%
0.00%
Q4 2022$34,610
-86.7%
53,320
-64.8%
0.00%
-100.0%
Q3 2022$260,000
+45.3%
151,370
+5.1%
0.00%
+100.0%
Q2 2022$179,000
-56.8%
144,025
-62.1%
0.00%
-66.7%
Q4 2021$414,000
+226.0%
379,766
+689.6%
0.00%
+200.0%
Q2 2021$127,000
+28.3%
48,099
+22.9%
0.00%0.0%
Q4 2020$99,000
+37.5%
39,141
+32.7%
0.00%
-66.7%
Q1 2020$72,00029,4880.00%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q3 2023
NameSharesValueWeighting ↓
MSD Partners, L.P. 10,986,258$20,544,0001.80%
Third Security, LLC 4,364,080$8,161,0001.11%
MILLER VALUE PARTNERS, LLC 9,264,700$16,617,0000.75%
Sargent Investment Group, LLC 188,950$353,0000.22%
Chessman Wealth Strategies RIA 72,050$135,0000.14%
Ibex Investors LLC 403,650$755,0000.12%
Old West Investment Management, LLC 223,319$417,0000.11%
PIPER SANDLER & CO. 34,222$64,0000.07%
Virtus ETF Advisers LLC 102,888$192,0000.03%
G&S Capital LLC 18,000$34,0000.03%
View complete list of ZIOPHARM ONCOLOGY INC shareholders